Decorative banner announcing event

Participate in the world's leading virtual stem cell event October 18-22, 2021

View past presentations

Last year, over 1,500 researchers from around the world gathered at the Gibco 5 Days of Stem Cells Virtual Event to discover the latest stem cell techniques and research breakthroughs—all from the comfort of anywhere.

The 5-day virtual agenda is packed full of incredible insights in the form of:

  • Leading scientific presentations from thought leaders
  • Scientific poster presentations
  • Virtual training opportunities
  • Key stem cell tools and resources
  • A global network of esteemed scientists

This year's event will be taking place October 18-22, 2021. Additional details, including registration and an agenda, will be available shortly. Be sure to check back for the latest!

Share your research with 3,000+ researchers worldwide!

If you'd like to share your latest discoveries at this renowned virtual stem cell conference, contact the event coordinator at chelsie.wajda@thermofisher.com.

Check out the rock-star speaker lineup and scientific resources from last year's virtual event:

The 2020 agenda featured cutting-edge research from thought leaders across the globe.

Keynote presentations

Heart disease in a dish: human iPSC-derived multicellular cardiac organoids
Jarmon Lees, St. Vincent's Institute of Medical Research
A high-throughput functional screen reveals human embryonic stem cell self-renewal signals
Jean Lu, Genomics Research Center, Academia Sinica
Personalized Immuno-Neuroscience and Glio-Immunology: Towards Human Culture Models of Innate Responses In The Brain
Julien Muffat, The Hospital for Sick Children & University of Toronto
Human iPSC-Based Disease Modeling and Therapeutic Development
Yanhong Shi, Beckman Research Institute of City of Hope
A human stem cell based model for retinoblastoma
Laura Steenpass, Institute of Human Genetics, University Hospital Essen

Presentations

Addressing the Needs of 3D Suspension Culture Systems Through the Optimization of a New PSC Medium
Michael Akenhead, Thermo Fisher Scientific
Stem cell therapies for skin regeneration in animal models, Costa Rica experiences
Silvia Castro Piedra & Johan Morales Sanchez, Costa Rica Institute of Technology
Optimization and Standardization in Stem Cell Manufacturing for the Fight Against COVID-19
Donna Chang, Hope Biosciences
Rotea: A Versatile Cell Therapy Workflow Instrument for Cell Isolation, Washing, and Concentration
Carl Dargitz, Thermo Fisher Scientific
Modelling disorders of the brain through patient-derived stem cells
Thomas Durcan, McGill University
Optimizing Stem Cells Workflows to Build Better Disease Models
Omar Farah, Thermo Fisher Scientific
Using iPS-derived cells to generate a functional human liver through 3D bioprinting
Ernesto Goulart, University of Sao Paulo
In vitro models of human neurogenesis
Larisa Haupt, Queensland University of Technology
Personalized cell therapy for Parkinson’s disease
Kwang-Soo Kim, McLean Hospital/Harvard Medical School
Epigenetic regulation of human naïve pluripotency
Ritu Kumar, Weill Cornell Medicine
Differentiation of iPSCs in 3D: Leveraging Suspension Cultures for Scale and Efficiency
David Kuninger, Thermo Fisher Scientific
Insulin-Producing Islets to Combat Diabetes from Stem Cells
Jeff Millman, Washington University School of Medicine
Development of a robust and scalable culture platform for expansion and neural induction of human pluripotent stem cells in suspension culture
Cláudia Miranda, Institute for Bioengineering and Biosciences (iBB), University of Lisbon
Using Stem Cells in Cartilage Repair and Tissue Engineering
Laila Montaser, Menoufia University
Characterization of human iPSC-derived neurons by transcriptomics and proteomics for drug discovery
Naomi Okugawa & Dirk Walther, Biogen
Transitioning from Discovery and Development to Manufacturing–Challenges and Opportunities
Rupa Pike, Thermo Fisher Scientific
Human stem cell derived cardiomyocytes for healthcare translation: compound screening and tissue engineering
Soong Poh Loong, National University of Singapore &Ternion Biosciences
Advanced Tools for Knock-in Genome Editing in iPSCs
Matt Poling, Thermo Fisher Scientific
New enabling technologies for 3D quantitative cellular biology using High-Content Screening
Nick Radio, Thermo Fisher Scientific
Organoid models of Glioblastoma
Richa Singhania, Weill Cornell Medicine
Advancing pluripotent stem cell technologies for research and therapy of blood diseases
Igor Slukvin, University of Wisconsin
Understanding human pluripotent states and their applications
Thor Theunissen, Washington University School of Medicine
Molecular dynamics associated with development of human GABAergic interneurons
Zhexing Wen, Emory University School of Medicine
iPSC-Based High Throughput Platforms for Screening Novel Therapeutics for Treatment of Alzheimer's Disease and Parkinson’s Disease
Jiayin Yang, Cell Inspire Therapeutics

The following posters were presented by Thermo Fisher Scientific R&D scientists.

3D Midbrain Floor Plate Model for Differentiation of PSC-derived Dopaminergic Neurons
Richard Josephson
Cracking the differentiation potential: biological models to advance stem cell research
Jamuna KS
Creation and characterization of T cell-derived iPSC banks derived using reagents and workflows optimized for cell therapy manufacturing​
Chad MacArthur
Development of a new 3D pluripotent stem cell suspension culture medium with a simplified protocol that yields highly efficient spheroid nucleation and robust expansion
Michael Akenhead
Development of a Robust Next Generation Feeder-Free Pluripotent Stem Cell Medium
Lauren Sangenario
Development of feeder-free PSC culture system enabling translation and clinical research
Lauren Sangenario
Establishing and functional characterization of 3D neural spheroid models from monolayer expanded NSCs​
Jonathan Sagal
Facilitated genome editing in human iPSC to advance disease modeling and screening​
Erik Willems
Scaled expansion of human pluripotent stem cells (hPSC) in suspension culture followed by high-yield factor-driven generation of induced neuronsfrom 3D PSC spheroids
Michael Derr

The 2020 event featured a variety of virtual training opportunities, including:

Self-guided virtual laboratories:

  • Pluripotent stem cell culture
  • Cell culture basics
  • Transfection basics
  • Protein expression basics
     

Live behind-the-scene training demonstrations given by Thermo Fisher Scientific R&D scientists:

  • Pluripotent stem cell picking
  • Routine passaging
  • Generating Central Nervous System (CNS) neurons
  • Designing the genome editing strategies for stem cells
  • Single cell sorting of genome edited iPSC pools
  • Transfection using the Invitrogen Neon Transfection System
  • Characterization assays for human induced pluripotent stem cells
  • 3D neural organoid formation from induced pluripotent stem cells
  • Cancer spheroid formation using Thermo Scientific Nunclon Sphera Microplates
     

eLearning modules:

  • Thawing induced pluripotent stem cells using Gibco StemFlex Medium
  • Gene editing in pluripotent stem cells
  • Innovation in stem cell suspension–Gibco StemScale PSC Suspension Medium
  • Neural organoid generation from pluripotent stem cells

Get an exclusive look at the premier virtual stem cell event

Here’s what attendees had to say about the event:


Tradeshow
Virtual event